Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-dose Fentanyl Matrix Application for Cancer Pain: Multicenter, Prospective, Observational Study

NCT01816503 is registered in ClinicalTrials.gov with Janssen Korea, Ltd., Korea as lead sponsor.

NCT NCT01816503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01816503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-dose Fentanyl Matrix Application for Cancer Pain: Multicenter, Prospective, Observational Study
Lead sponsor
Janssen Korea, Ltd., Korea
Phase
Observational
Overall status
Completed
Start date
December 31, 2008
Completion date
July 31, 2009
Enrollment
636 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pain